Home
Scholarly Works
COST-EFFECTIVENESS OF EMICIZUMAB PROPHYLAXIS IN...
Conference

COST-EFFECTIVENESS OF EMICIZUMAB PROPHYLAXIS IN PATIENTS WITH HEMOPHILIA A WITHOUT INHIBITORS

Authors

Olasupo O; Matino D; Iorio A; Blackhouse G; Xie F; Tarride JE

Volume

25

Pagination

pp. S428-S428

Publisher

ELSEVIER SCIENCE INC

Publication Date

July 1, 2022

Conference proceedings

VALUE IN HEALTH

Issue

7

ISSN

1098-3015

Associated Experts

Alfonso Iorio

Professor, Health Research Methods, Evidence, and Impact
Visit profile

Davide Matino

Associate Professor, Medicine
Visit profile

Jean-Eric Tarride

Professor, Health Research Methods, Evidence, and Impact
Visit profile

Omotola Olasupo

Assistant Professor (Part-Time), Health Research Methods, Evidence, and Impact
Visit profile

Labels

Fields of Research (FoR)

3801 Applied economics4203 Health services and systems4407 Policy and administration

Contact the Experts team

Get technical help
or
Provide website feedback